$FRGT
Freight Technologies, Inc. Stock $frgt

$frgt Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000149315224018375 Filed on May 09, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$9.442M	$17.06M	$25.89M
YoY Change	-21.71%	-34.1%
Cost Of Revenue	$8.773M	$15.71M	$23.63M
YoY Change	-16.82%	-33.5%
Gross Profit	$669.0K	$1.351M	$2.263M
YoY Change	-55.8%	-40.3%
Gross Profit Margin	7.09%	7.92%	8.74%
Selling, General & Admin	$5.243M	$3.244M	$4.118M
YoY Change	7.22%	-21.23%	65.03%
% of Gross Profit	783.71%	240.12%	181.96%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$213.0K	$404.6K	$243.3K
YoY Change	92.38%	66.27%	7504.19%
% of Gross Profit	31.84%	29.95%	10.75%
Operating Expenses	$5.455M	$3.244M	$4.118M
YoY Change	9.08%	-21.23%	65.03%
Operating Profit	-$4.786M	-$8.261M	-$7.062M
YoY Change	37.24%	16.99%	183.0%
Interest Expense	$252.0K	$807.9K	$907.0K
YoY Change	-207.72%	-10.92%	119243.82%
% of Operating Profit
Other Income/Expense, Net	-$499.0K	-$498.9K	-$128.1K
YoY Change	289.69%	289.63%	-136.69%
Pretax Income	-$5.033M	-$9.223M	-$8.097M
YoY Change	30.75%	13.91%	277.37%
Income Tax	$72.00K	$104.9K	$90.51K
% Of Pretax Income
Net Earnings	-$5.105M	-$9.328M	-$8.187M
YoY Change	30.59%	13.93%	281.59%
Net Earnings / Revenue	-54.07%	-54.67%	-31.62%
Basic Earnings Per Share		-$7.79	-$2.10
Diluted Earnings Per Share	-$2.95	-$7.79	-$2.10
COMMON SHARES
Basic Shares Outstanding	21.92M shares	1.197M shares	3.906M shares
Diluted Shares Outstanding		1.197M shares	390.6K shares

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.560M	$1.560M	$1.013M
YoY Change	54.0%	54.0%	357.73%
Cash & Equivalents	$1.600M	$1.560M	$1.013M
Short-Term Investments
Other Short-Term Assets	$1.884M	$1.884M	$1.572M
YoY Change	19.86%	19.86%	5651.37%
Inventory
Prepaid Expenses
Receivables	$5.360M	$5.360M	$4.983M
Other Receivables	$962.0K	$962.0K	$1.891M
Total Short-Term Assets	$9.766M	$9.766M	$9.459M
YoY Change	3.25%	3.25%	243.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$46.55K	$47.00K	$27.61K
YoY Change	68.62%	70.23%	149.41%
Goodwill
YoY Change
Intangibles	$6.359K
YoY Change	-11.34%
Long-Term Investments	$8.000K	$8.000K	$18.17K
YoY Change	-55.97%	-55.97%
Other Assets	$80.67K	$81.00K	$154.1K
YoY Change	-47.64%	-47.42%
Total Long-Term Assets	$912.5K	$913.0K	$956.9K
YoY Change	-4.63%	-4.58%	8535.92%
TOTAL ASSETS
Total Short-Term Assets	$9.766M	$9.766M	$9.459M
Total Long-Term Assets	$912.5K	$913.0K	$956.9K
Total Assets	$10.68M	$10.68M	$10.42M
YoY Change	2.53%	2.53%	276.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.876M	$1.876M	$1.981M
YoY Change	-5.3%	-5.28%
Accrued Expenses	$2.881M	$2.881M	$1.795M
YoY Change	60.53%	60.54%
Deferred Revenue
YoY Change
Short-Term Debt	$2.820M	$2.820M	$3.347M
YoY Change	-15.77%	-15.75%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.810M	$7.810M	$7.284M
YoY Change	7.21%	7.22%	5853.53%
LONG-TERM LIABILITIES
Long-Term Debt	$242.0K	$242.0K	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$242.0K	$242.0K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.810M	$7.810M	$7.284M
Total Long-Term Liabilities	$242.0K	$242.0K	$0.00
Total Liabilities	$8.052M	$8.052M	$7.284M
YoY Change	10.54%	10.54%	5853.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.30M
YoY Change	31.0%
Common Stock	$2.411M
YoY Change	1230.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.600M	$2.627M	$3.131M
YoY Change
Total Liabilities & Shareholders Equity	$10.68M	$10.68M	$10.42M
YoY Change	2.53%	2.53%	276.63%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	-$5.105M	-$9.328M	-$8.187M
YoY Change	30.59%	13.93%	281.59%
Depreciation, Depletion And Amortization	$213.0K	$404.6K	$243.3K
YoY Change	92.38%	66.27%	7504.19%
Cash From Operating Activities		-$5.791M	-$8.470M
YoY Change		-31.63%	74.47%
INVESTING ACTIVITIES
Capital Expenditures		$34.72K	$16.91K
YoY Change		105.31%	-414.95%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$363.4K	-$380.6K
YoY Change		-4.52%	-83.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$2.356M
YoY Change		-100.0%	-34.54%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$6.801M	$6.572M
YoY Change		3.47%	82.59%
NET CHANGE
Cash From Operating Activities		-$5.791M	-$8.470M
Cash From Investing Activities		-$363.4K	-$380.6K
Cash From Financing Activities		$6.801M	$6.572M
Net Change In Cash		$646.7K	-$2.278M
YoY Change		-128.39%	-36.91%
FREE CASH FLOW
Cash From Operating Activities		-$5.791M	-$8.470M
Capital Expenditures		$34.72K	$16.91K
Free Cash Flow		-$5.825M	-$8.487M
YoY Change		-31.36%	75.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001687542
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D8
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2022	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	FRGT	Loss On Initial Issuance Of Private Warrants LossOnInitialIssuanceOfPrivateWarrants		usd
CY2022	FRGT	Loss On Initial Issuance Of Private Warrants LossOnInitialIssuanceOfPrivateWarrants		usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022	FRGT	Change In Fair Value Of Convertible Note ChangeInFairValueOfConvertibleNote		usd
CY2021	FRGT	Change In Fair Value Of Convertible Note ChangeInFairValueOfConvertibleNote		usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023	FRGT	Stock Issued During Period Value Issuance Of Ordinary Shares From Conversion Of Preferred Stock Net Of Costs StockIssuedDuringPeriodValueIssuanceOfOrdinarySharesFromConversionOfPreferredStockNetOfCosts		usd
CY2023	FRGT	Stock And Warrants Issued During Period Value Common Stock And Warrants StockAndWarrantsIssuedDuringPeriodValueCommonStockAndWarrants		usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023	FRGT	Amortization Of Debt Issuance Costs And Debt Discount AmortizationOfDebtIssuanceCostsAndDebtDiscount		usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
CY2023	FRGT	Loss On Initial Issuance Of Private Warrants LossOnInitialIssuanceOfPrivateWarrants		usd
CY2022	FRGT	Loss On Initial Issuance Of Private Warrants LossOnInitialIssuanceOfPrivateWarrants		usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022	FRGT	Change In Fair Market Value Of Convertible Note ChangeInFairMarketValueOfConvertibleNote		usd
CY2021	FRGT	Change In Fair Market Value Of Convertible Note ChangeInFairMarketValueOfConvertibleNote		usd
CY2022	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense		usd
CY2021	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense		usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2023	FRGT	Gains Losses From Extinguishment Of Debt GainsLossesFromExtinguishmentOfDebt		usd
CY2022	FRGT	Gains Losses From Extinguishment Of Debt GainsLossesFromExtinguishmentOfDebt		usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties		usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties		usd
CY2021	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits		usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans		usd
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2023	FRGT	Proceeds From Issuance Of Preferred Stock ProceedsFromIssuanceOfPreferredStock		usd
CY2021	FRGT	Proceeds From Issuance Of Preferred Stock ProceedsFromIssuanceOfPreferredStock		usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2023	FRGT	Conversion Of Convertible Notes To Preferred Stock At Merger ConversionOfConvertibleNotesToPreferredStockAtMerger		usd
CY2021	FRGT	Conversion Of Convertible Notes To Preferred Stock At Merger ConversionOfConvertibleNotesToPreferredStockAtMerger		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2021	us-gaap	Stock Issued1 StockIssued1		usd
CY2023	FRGT	Debt Discount In Connection With Note Payable DebtDiscountInConnectionWithNotePayable		usd
CY2022	FRGT	Debt Discount In Connection With Note Payable DebtDiscountInConnectionWithNotePayable		usd
CY2023	FRGT	Elimination Of Notes Payable From Consolidation Upon Merger EliminationOfNotesPayableFromConsolidationUponMerger		usd
CY2021	FRGT	Elimination Of Notes Payable From Consolidation Upon Merger EliminationOfNotesPayableFromConsolidationUponMerger		usd
CY2023	FRGT	Repayment Of Note Payable Through Issuance Of Series A4 Shares RepaymentOfNotePayableThroughIssuanceOfSeriesA4Shares		usd
CY2021	FRGT	Repayment Of Note Payable Through Issuance Of Series A4 Shares RepaymentOfNotePayableThroughIssuanceOfSeriesA4Shares		usd
CY2023	FRGT	Issuance Of Ordinary Shares For Professional Services IssuanceOfOrdinarySharesForProfessionalServices		usd
CY2021	FRGT	Issuance Of Ordinary Shares For Professional Services IssuanceOfOrdinarySharesForProfessionalServices		usd
CY2022	FRGT	Conversion Of Convertible Notes To Preferred Stock ConversionOfConvertibleNotesToPreferredStock		usd
CY2021	FRGT	Conversion Of Convertible Notes To Preferred Stock ConversionOfConvertibleNotesToPreferredStock		usd
CY2022	FRGT	Conversion Of Convertible Notes To Ordinary Shares ConversionOfConvertibleNotesToOrdinaryShares		usd
CY2021	FRGT	Conversion Of Convertible Notes To Ordinary Shares ConversionOfConvertibleNotesToOrdinaryShares		usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2021	FRGT	Conversion Of Warrants To Ordinary Shares ConversionOfWarrantsToOrdinaryShares		usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2022Q4	FRGT	Accrued Interest On Convertible Note AccruedInterestOnConvertibleNote		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2022	FRGT	Income Tax Reconciliation Earnings Foreign Subsidy IncomeTaxReconciliationEarningsForeignSubsidy		usd
CY2021	FRGT	Income Tax Reconciliation Earnings Foreign Subsidy IncomeTaxReconciliationEarningsForeignSubsidy		usd
CY2022	FRGT	Income Tax Reconciliation Foreign Taxes IncomeTaxReconciliationForeignTaxes		usd
CY2021	FRGT	Income Tax Reconciliation Foreign Taxes IncomeTaxReconciliationForeignTaxes		usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems		usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities		usd
CY2022Q4	FRGT	Deferred Tax Assets Tax Deferred Expense Stock Option DeferredTaxAssetsTaxDeferredExpenseStockOption		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	FRGT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice
CY2023	FRGT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38172
CY2023	dei	Entity Registrant Name EntityRegistrantName	FREIGHT TECHNOLOGIES, INC.
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2001 Timberloch Place
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	The Woodlands
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77380
CY2023	dei	Security12b Title Security12bTitle	Ordinary shares, par value $1.10 per share
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21919240	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Name AuditorName	UHY LLP
CY2023	dei	Auditor Location AuditorLocation	Melville, New York
CY2023	dei	Auditor Firm AuditorFirmId	1195
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1560105	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1013000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5360493	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4982873	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	961747	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	1891023	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1884067	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1571853	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9766412	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9458749	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	771133	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	749855	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46550	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27607	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	80674	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	154062	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	7818	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	18166	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6359	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7172	usd
CY2023Q4	us-gaap	Assets Assets	10678946	usd
CY2022Q4	us-gaap	Assets Assets	10415611	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1875727	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1980619	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2880805	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1794575	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	2819620	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	3347374	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	220180	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	143518	usd
CY2023Q4	us-gaap	Financial Services Liabilities FinancialServicesLiabilities	13191	usd
CY2022Q4	us-gaap	Financial Services Liabilities FinancialServicesLiabilities	18062	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7809523	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7284148	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	242442	usd
CY2023Q4	us-gaap	Liabilities Liabilities	8051965	usd
CY2022Q4	us-gaap	Liabilities Liabilities	7284148	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.10
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.10
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2191924	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2191924	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	164688	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	164688	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2411118	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	181157	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39023126	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32897836	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39315551	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29987945	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	491888	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	38971	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2626981	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3131463	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10678946	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10415611	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17060753	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25888436	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21474151	usd
CY2023	FRGT	Cost Of Revenue Exclusive Of Depreciation And Amortization CostOfRevenueExclusiveOfDepreciationAndAmortization	15709673	usd
CY2022	FRGT	Cost Of Revenue Exclusive Of Depreciation And Amortization CostOfRevenueExclusiveOfDepreciationAndAmortization	23625317	usd
CY2021	FRGT	Cost Of Revenue Exclusive Of Depreciation And Amortization CostOfRevenueExclusiveOfDepreciationAndAmortization	19558807	usd
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	5963713	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	4963306	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3712325	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3163639	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3560615	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2618126	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	80328	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	557471	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	91657	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	404598	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	243334	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	302100	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	25321951	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	32950043	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	26283015	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-8261198	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-7061607	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-4808864	usd
CY2023	us-gaap	Interest Expense InterestExpense	807939	usd
CY2022	us-gaap	Interest Expense InterestExpense	907013	usd
CY2021	us-gaap	Interest Expense InterestExpense	1136096	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	115725	usd
CY2021	FRGT	Loss On Initial Issuance Of Private Warrants LossOnInitialIssuanceOfPrivateWarrants	2829065	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-498917	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	128051	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-497759	usd
CY2023	FRGT	Change In Fair Value Of Convertible Note ChangeInFairValueOfConvertibleNote	345396	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9222658	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8096671	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8160541	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	104948	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	90511	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40264	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9327606	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-8187182	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-8200805	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.79
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.79
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-20.96
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-20.96
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-105.35
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-105.35
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1196668	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1196668	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	390563	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	390563	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77844	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77844	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9327606	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-8187182	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-8200805	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	452917	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	88881	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-50540	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8874689	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8098301	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8251345	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1147016	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	235404	usd
CY2021	FRGT	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	191465	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-50540	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-8200805	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-8971492	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	11655118	usd
CY2022	FRGT	Issuance Of Series B Preferred Shares Related To Pipe Investment IssuanceOfSeriesBPreferredSharesRelatedToPIPEInvestment	3500000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2432430	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2100	usd
CY2022	FRGT	Issuance Of Ordinary Shares For Cash Net Of Issuance Costs IssuanceOfOrdinarySharesForCashNetOfIssuanceCosts	935000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	483000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	189216	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	1004392	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	88881	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-8187182	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3131463	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3131463	usd
CY2023	FRGT	Stock Issued During Period Value Issuance Of Preferred Shares For Note Conversions StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForNoteConversions	5117096	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	755470	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	1153787	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1343854	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	452917	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9327606	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2626981	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2626981	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9327606	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-8187182	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-8200805	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	404598	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	243334	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	302100	usd
CY2022	FRGT	Amortization Of Debt Issuance Costs And Debt Discount AmortizationOfDebtIssuanceCostsAndDebtDiscount	539975	usd
CY2021	FRGT	Amortization Of Debt Issuance Costs And Debt Discount AmortizationOfDebtIssuanceCostsAndDebtDiscount	592874	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1153787	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1004392	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	235404	usd
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	449147	usd
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	313404	usd
CY2021	FRGT	Loss On Initial Issuance Of Private Warrants LossOnInitialIssuanceOfPrivateWarrants	2829065	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	128051	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-497759	usd
CY2023	FRGT	Change In Fair Market Value Of Convertible Note ChangeInFairMarketValueOfConvertibleNote	345396	usd
CY2023	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	129259	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	483000	usd
CY2021	FRGT	Gains Losses From Extinguishment Of Debt GainsLossesFromExtinguishmentOfDebt	115678	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-45383	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2006568	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1309208	usd
CY2023	FRGT	Increase Decrease In Unbilled Receivable IncreaseDecreaseInUnbilledReceivable	-1070440	usd
CY2022	FRGT	Increase Decrease In Unbilled Receivable IncreaseDecreaseInUnbilledReceivable	596082	usd
CY2021	FRGT	Increase Decrease In Unbilled Receivable IncreaseDecreaseInUnbilledReceivable	241483	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-24010	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-288272	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	684100	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	591520	usd
CY2023	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	11457	usd
CY2022	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	16936	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-181880	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-292520	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	526375	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	435193	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	810823	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	163223	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	76662	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	70222	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	40264	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5790684	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8469719	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5929734	usd
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	328645	usd
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	363665	usd
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	457874	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34724	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16913	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12528	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-363369	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-380578	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-470402	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	7675000	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3608842	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2100	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	191457	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	400000	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2620000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	400000	usd
CY2023	FRGT	Repayment Of Insurance Financing Payable RepaymentOfInsuranceFinancingPayable	-346524	usd
CY2022	FRGT	Repayment Of Insurance Financing Payable RepaymentOfInsuranceFinancingPayable	-399633	usd
CY2021	FRGT	Repayment Of Insurance Financing Payable RepaymentOfInsuranceFinancingPayable	-18946	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	189216	usd
CY2023	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	19385421	usd
CY2022	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	22554467	usd
CY2021	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	19273922	usd
CY2023	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	18857667	usd
CY2022	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	24169960	usd
CY2021	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	19705788	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2356178	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	2500000	usd
CY2022	FRGT	Proceeds From Issuance Of Preferred Stock ProceedsFromIssuanceOfPreferredStock	3500000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3190866	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6800722	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6572488	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6833219	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	646669	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2277809	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	433083	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-99564	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-37184	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-46581	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1013000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3327993	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2941491	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1560105	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1013000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3327993	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	816819	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	392018	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	263788	usd
CY2022	FRGT	Conversion Of Convertible Notes To Preferred Stock At Merger ConversionOfConvertibleNotesToPreferredStockAtMerger	7878025	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	3312093	usd
CY2023	FRGT	Financing Of Insurance Premiums FinancingOfInsurancePremiums	341653	usd
CY2022	FRGT	Financing Of Insurance Premiums FinancingOfInsurancePremiums	409575	usd
CY2021	FRGT	Financing Of Insurance Premiums FinancingOfInsurancePremiums	27066	usd
CY2021	FRGT	Debt Discount In Connection With Note Payable DebtDiscountInConnectionWithNotePayable	30000	usd
CY2022	FRGT	Elimination Of Notes Payable From Consolidation Upon Merger EliminationOfNotesPayableFromConsolidationUponMerger	2450000	usd
CY2022	FRGT	Repayment Of Note Payable Through Issuance Of Series A4 Shares RepaymentOfNotePayableThroughIssuanceOfSeriesA4Shares	200000	usd
CY2022	FRGT	Issuance Of Ordinary Shares For Professional Services IssuanceOfOrdinarySharesForProfessionalServices	270000	usd
CY2023	FRGT	Conversion Of Convertible Notes To Preferred Stock ConversionOfConvertibleNotesToPreferredStock	7054065	usd
CY2023	FRGT	Conversion Of Convertible Notes To Ordinary Shares ConversionOfConvertibleNotesToOrdinaryShares	1040000	usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	1368907	usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	60218	usd
CY2023	FRGT	Conversion Of Warrants To Ordinary Shares ConversionOfWarrantsToOrdinaryShares	60253	usd
CY2022	FRGT	Conversion Of Warrants To Ordinary Shares ConversionOfWarrantsToOrdinaryShares	4825	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1560105	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1013000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3152993	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	175000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1560105	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1013000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3327993	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39300000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2600000	usd
CY2023Q4	FRGT	Working Capital WorkingCapital	2000000.0	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	2800000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1600000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_ztuF3vq77JSe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_z2Js4HSs7Sy9">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Such estimates include, but are not limited to, allowance for credit losses, valuation of share-based compensation and warrants, accounting for warrants, useful lives of internally developed software and property and equipment, fair value of convertible notes, impairment of long lived assets, whether an arrangement is or contains a lease, income tax accruals, the valuation allowance for deferred income taxes, and contingent liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FREIGHT TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_ztg1tnoWCqJ8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zvFn3sj9GUje">Concentrations of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains cash accounts with various financial institutions. At times, balances in these accounts may exceed federally insured limits. Accounts at each institution within the United States (“US”) are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $<span id="xdx_90A_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zfExM2guXus9" title="Federal deposit insurance corporation">250,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Additionally, a portion of the Company’s cash is deposited in non-US accounts. The funds are held with financial institutions that offer deposit insurance and bear specific country and regional risks. The amounts over the insured limits as of December 31, 2023 and 2022 was $<span id="xdx_903_eus-gaap--CashUninsuredAmount_iI_c20231231_zwa5qGwRlwo2" title="Insured limits">1,186,214</span> and $<span id="xdx_90B_eus-gaap--CashUninsuredAmount_iI_c20221231_zRzfRNUg6yIj" title="Insured limits">449,991</span></span>, respectively. No losses have been incurred to date on any deposit balances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial assets that potentially subject the Company to concentration of credit risk is accounts receivable and unbilled receivables. At December 31, 2023, one customer accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zsQiyPGLYIcg" title="Concentration risk, percentage">66</span>% of the Company’s accounts receivable. As of December 31, 2022, two customers accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zHSPnQDwevI7" title="Concentration risk, percentage">42</span>% </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z813k7Vadzak" title="Concentration risk, percentage">16</span>% </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the Company’s accounts receivable, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2023, one customer accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_znyIZtAmzzZ1" title="Concentration risk, percentage">33</span>% of the Company’s revenues. For the year ended December 31, 2022, two customers accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zIKKhR7je3dg" title="Concentration risk, percentage">17</span>% </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zz3gumFyk186" title="Concentration risk, percentage">11</span>% </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the Company’s revenues, respectively. For the year ended December 31, 2021, one customer accounted for 37% of the Company’s revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1186214	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	449991	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	282058	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	171009	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	46726	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	43299	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	421	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17060753	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25888436	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21474151	usd
CY2022Q4	FRGT	Accrued Freight Costs AccruedFreightCosts	947372	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1246687	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	63671	shares
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2450000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	3594249	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	3178850	usd
CY2023Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	2823116	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	2428995	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	771133	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	749855	usd
CY2023	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	385488	usd
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	225447	usd
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	285069	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	386591	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	326062	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	58480	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	771133	usd
CY2023Q4	FRGT	Accrued Freight Costs AccruedFreightCosts	1057374	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	134351	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	94323	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	87801	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	66716	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46550	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27607	usd
CY2023	us-gaap	Depreciation Depreciation	19110	usd
CY2022	us-gaap	Depreciation Depreciation	17887	usd
CY2021	us-gaap	Depreciation Depreciation	16130	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	716278	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	416039	usd
CY2023Q4	FRGT	Accrued Value Added Tax AccruedValueAddedTax	641634	usd
CY2022Q4	FRGT	Accrued Value Added Tax AccruedValueAddedTax	386083	usd
CY2023Q4	FRGT	Accrued Interest On Convertible Note AccruedInterestOnConvertibleNote	449146	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1006	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	41554	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	15367	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3527	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2880805	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1794575	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0358	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0439	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.00986	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0344	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.8312	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.9232	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.7362	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.8345	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15812	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	133.59
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	33477	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	179.00
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5771	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	148.00
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4364	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	43.36
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	39154	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	180.22
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y1M9D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	37490	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	18.23
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1383	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	191.88
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	75261	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	99.32
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y8M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	17311	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	174.84
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y9M21D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	7002	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	58.80
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	33477	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	108.77
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	5381	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	77.70
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	2563	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	38.00
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	32535	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	102.99
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	37490	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	12.37
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	424	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	3.42
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	11651	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	98.98
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	57950	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	45.33
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1092820	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	555156	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	171500	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2752366	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	7675000	usd
CY2023	FRGT	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Allocation Of Warrants FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAllocationOfWarrants	-1214594	usd
CY2023	FRGT	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion Of Ordinary Shares FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfOrdinaryShares	-755470	usd
CY2023	FRGT	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion Of Preferred Shares FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfPreferredShares	-5117098	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-345396	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	242442	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	16625	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	41401	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	88323	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	49110	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	40264	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	104948	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	90511	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	40264	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	104948	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	90511	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40264	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9222658	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8096671	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8160541	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	104948	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	90511	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40264	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0114	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.011	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.005	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1936758	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1700301	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1713714	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-24108	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.002	pure
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-17442	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.002	pure
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-21754	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.003	pure
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-205230	usd
CY2023	FRGT	Effective Income Tax Rate Reconciliation Provision Adjustments EffectiveIncomeTaxRateReconciliationProvisionAdjustments	0.022	pure
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	911500	usd
CY2022	FRGT	Effective Income Tax Rate Reconciliation Provision Adjustments EffectiveIncomeTaxRateReconciliationProvisionAdjustments	-0.113	pure
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	5119	usd
CY2021	FRGT	Effective Income Tax Rate Reconciliation Provision Adjustments EffectiveIncomeTaxRateReconciliationProvisionAdjustments	-0.001	pure
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1952580	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.212	pure
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	720407	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.089	pure
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2295280	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.281	pure
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-227266	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0264	pure
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	166816	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.021	pure
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-528281	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.065	pure
CY2023	FRGT	Income Tax Reconciliation Earnings Foreign Subsidy IncomeTaxReconciliationEarningsForeignSubsidy	457407	usd
CY2023	FRGT	Effective Income Tax Rate Reconciliation Foreign Subsidy EffectiveIncomeTaxRateReconciliationForeignSubsidy	-0.049	pure
CY2023	FRGT	Income Tax Reconciliation Foreign Taxes IncomeTaxReconciliationForeignTaxes	88323	usd
CY2023	FRGT	Effective Income Tax Rate Reconciliation Foreign Taxes EffectiveIncomeTaxRateReconciliationForeignTaxes	-0.009	pure
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	9531	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.001	pure
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	3614	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.000	pure
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	104948	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0114	pure
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	90511	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.011	pure
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40264	usd
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.005	pure
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	33069147	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	25375000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	17817000	usd
CY2023	FRGT	Net Operating Losses Expiration Description NetOperatingLossesExpirationDescription	NOLs expire from 2035 to 2042
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	33069147	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	65011	usd
CY2023Q4	FRGT	Deferred Tax Assets Fixed And Intangible Assets DeferredTaxAssetsFixedAndIntangibleAssets	-173462	usd
CY2022Q4	FRGT	Deferred Tax Assets Fixed And Intangible Assets DeferredTaxAssetsFixedAndIntangibleAssets	54219	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	53807	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	13884	usd
CY2023Q4	FRGT	Deferred Tax Assets Tax Deferred Expense Stock Option DeferredTaxAssetsTaxDeferredExpenseStockOption	102019	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	208103	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	211142	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	6944521	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	5328850	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	225032	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	189695	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7706944	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5754363	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7706944	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5754363	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7706944	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5754363	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1952580	usd
CY2021Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
CY2021Q4	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2022-10-31
CY2022Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
CY2022Q4	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2023-11-01
CY2023Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
CY2023Q4	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2024-11-01
CY2023	us-gaap	Payments For Rent PaymentsForRent	101000	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	118000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	831860	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	802800	usd
CY2023	us-gaap	Revenues Revenues	17060753	usd
CY2022	us-gaap	Revenues Revenues	25888436	usd
CY2021	us-gaap	Revenues Revenues	21474151	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4000	shares
CY2022Q4	FRGT	Stock And Warrants Issued During Period Shares Common Stock And Warrants StockAndWarrantsIssuedDuringPeriodSharesCommonStockAndWarrants	21000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.10
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	164001382	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	14449669	shares
CY2022Q4	FRGT	Stock And Warrants Issued During Period Value Common Stock And Warrants StockAndWarrantsIssuedDuringPeriodValueCommonStockAndWarrants	1002100	usd
CY2021Q4	FRGT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	28.51
CY2022	FRGT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	193.92
CY2022	FRGT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised In Period Weighted Average Converted Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedInPeriodWeightedAverageConvertedPrice	210.03
CY2022	FRGT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedInPeriodWeightedAverageExercisePrice	0.10
CY2022Q4	FRGT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	233.28
CY2023	FRGT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	134.96
CY2023	FRGT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised In Period Weighted Average Converted Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedInPeriodWeightedAverageConvertedPrice	247.88
CY2023Q4	FRGT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	136.66
CY2023	us-gaap	Description Of Defined Contribution Pension And Other Postretirement Plans DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans	The Company has a defined contribution plan covering eligible employees with at least two months of service. The Company fully matches employee contributions up to 3% of total compensation, plus 50% of contributions that exceed that amount up to 5% of total compensation.
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	31187	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	23758	usd
CY2022Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	The Board of Directors of Hudson Capital approved a reverse stock split of 2.2:1 of Hudson Capital on January 21, 2022, effective as of February 14, 2022. Hudson Capital’s ordinary shares began trading on a split adjusted basis on February 15, 2022.
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	The Company effected a ten for one reverse stock split on March 24, 2023. All ordinary shares and per ordinary share information in these consolidated financial statements has been retroactively adjusted to reflect this reverse stock split. All classes of preferred shares were not subject to this reverse stock split prior to conversion to ordinary shares.
CY2023	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	Series A1-A: 0.015, Series A2: 0.022, Series A4: 0.015, Series B: 0.047, Series Seed: 0.01
CY2023	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	0.779 of Company’s Ordinary share will be issued for each Series A Warrant, 0.816 Ordinary share shall be issued for each Series B Warrant, 0.888 Ordinary share shall be issued for each Series C Warrant and 0.826 Ordinary share shall be issued for each Series D Warrant.
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	6300	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.10
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	2100	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.10
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	12600	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.10
CY2022	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	54745	shares
CY2022	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	4387	shares
CY2023	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1244461	shares
CY2023	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	547758	shares

Files In Submission

Name	View Source	Status
0001493152-24-018375-index-headers.html	Edgar Link	pending
0001493152-24-018375-index.html	Edgar Link	pending
0001493152-24-018375.txt	Edgar Link	pending
0001493152-24-018375-xbrl.zip	Edgar Link	pending
aud_001.jpg	Edgar Link	pending
ex10-30.htm	Edgar Link	pending
ex12-1.htm	Edgar Link	pending
ex12-2.htm	Edgar Link	pending
ex13-1.htm	Edgar Link	pending
ex13-2.htm	Edgar Link	pending
ex19-1.htm	Edgar Link	pending
ex8-1.htm	Edgar Link	pending
ex97-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form20-f.htm	Edgar Link	pending
frgt-20231231.xsd	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
frgt-20231231_cal.xml	Edgar Link	unprocessable
frgt-20231231_def.xml	Edgar Link	unprocessable
frgt-20231231_lab.xml	Edgar Link	unprocessable
frgt-20231231_pre.xml	Edgar Link	unprocessable
form20-f_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FRGT
Freight Technologies, Inc. Stock $frgt

2023 Q4 Form 20-F Financial Statement

#000149315224018375 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FRGT Freight Technologies, Inc. Stock $frgt

2023 Q4 Form 20-F Financial Statement

#000149315224018375 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FRGT
Freight Technologies, Inc. Stock $frgt